| Breakdown | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 94.13B | 78.44B | 66.93B | 60.82B | 51.72B |
| Gross Profit | 27.17B | 49.20B | 44.02B | 41.00B | 34.82B |
| EBITDA | 31.51B | 33.70B | 29.48B | 27.61B | 22.63B |
| Net Income | 18.80B | 20.03B | 18.09B | 16.15B | 14.29B |
Balance Sheet | |||||
| Total Assets | 92.47B | 93.50B | 83.31B | 78.58B | 70.48B |
| Cash, Cash Equivalents and Short-Term Investments | 46.47B | 50.86B | 37.70B | 36.45B | 34.30B |
| Total Debt | 3.19B | 4.25B | 5.18B | 5.96B | 6.60B |
| Total Liabilities | 27.30B | 31.37B | 31.62B | 30.42B | 22.31B |
| Stockholders Equity | 64.99B | 61.81B | 51.38B | 47.88B | 47.96B |
Cash Flow | |||||
| Free Cash Flow | 24.61B | 26.79B | 19.25B | 22.04B | 15.65B |
| Operating Cash Flow | 25.36B | 27.49B | 19.53B | 22.59B | 16.03B |
| Investing Cash Flow | -11.42B | -3.02B | -2.23B | -2.87B | -1.31B |
| Financing Cash Flow | -18.37B | -11.30B | -16.08B | -17.57B | -15.31B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | ¥670.21B | 21.82 | 32.41% | 3.62% | 20.01% | -6.20% | |
75 Outperform | ¥13.30B | 13.32 | ― | ― | 15.73% | 19.43% | |
70 Outperform | ¥43.47B | 34.67 | ― | ― | 27.05% | 495.56% | |
66 Neutral | ¥25.90B | 7.74 | 22.37% | 5.66% | -8.47% | ― | |
60 Neutral | $48.67B | 4.58 | -11.27% | 4.14% | 2.83% | -41.78% | |
45 Neutral | ¥1.86B | 2,132.61 | ― | ― | -2.34% | ― | |
41 Neutral | ¥3.43B | 25.81 | ― | ― | 1.95% | -609.41% |